Aspire Biopharma Files Q1 2025 10-Q
Ticker: ASBPW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1847345
Sentiment: neutral
Topics: 10-Q, pharmaceutical, financials
Related Tickers: ASBP
TL;DR
Aspire Biopharma (ASBP) filed its Q1 2025 10-Q. Check financials.
AI Summary
Aspire Biopharma Holdings, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as PowerUp Acquisition Corp., is in the pharmaceutical preparations industry. The filing details financial information and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with an update on Aspire Biopharma's financial health and operational status for the first quarter of 2025, crucial for understanding its current trajectory.
Risk Assessment
Risk Level: medium — As a biopharma company, Aspire Biopharma is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of 2025 financial results are detailed.)
- 2025-03-31 — As of Date (The end date for the financial data presented in the report.)
Key Players & Entities
- Aspire Biopharma Holdings, Inc. (company) — Filer of the 10-Q
- PowerUp Acquisition Corp. (company) — Former name of Aspire Biopharma Holdings, Inc.
- 20250331 (date) — End of the reporting period
- 20250514 (date) — Filing date
- 001-41293 (dollar_amount) — SEC File Number
FAQ
What is the primary business of Aspire Biopharma Holdings, Inc.?
Aspire Biopharma Holdings, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on May 14, 2025.
What was the previous name of Aspire Biopharma Holdings, Inc.?
The company was formerly known as PowerUp Acquisition Corp. and PowsedrUp Acquisition Corp.
What is the fiscal year end for Aspire Biopharma Holdings, Inc.?
The company's fiscal year ends on December 31.
What is the business address of Aspire Biopharma Holdings, Inc.?
The business address is 194 Candelaro Drive, #233, Humacao, PR 00791.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Aspire Biopharma Holdings, Inc. (ASBPW).